Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of immunomodulatory drugs and compositions, applied in drug combinations, pharmaceutical formulations, pill delivery, etc., can solve the problems of short half-life, toxic and side effects, etc., and achieve the goal of improving the internal environment, anti-immune damage internal environment, and improving immune defense Effect
Inactive Publication Date: 2008-04-30
刘晓清
View PDF0 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0012] However, due to the short half-life of cytokine drugs in the human body, it is necessary to give patients high doses of repeated injections to achieve a certain effect, and this practice often leads to serious side effects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0027] Take interleukin-25000u, interferon 150000u, thymosin 500ug, transfer factor 1.5u, hydrocortisone 30000ug and add it to 800mL eggs, stir evenly, dry and crush into egg powder, fill into No. 2 capsules, and make 1000 capsules , each capsule contains egg powder 190mg, including interleukin-2 5u, interferon 150u, thymosin for injection 0.5ug, transfer factor 0.0015u, hydrocortisone 30ug.
Embodiment 2
[0029] Take interleukin-2 1500000u, interferon 50000u, thymosin 25000ug, transfer factor 0.02u, hydrocortisone 150000ug and add it to 800mL eggs, stir evenly, dry and crush into egg powder, fill it into No. 2 capsules, and make 1000 capsules Capsules, each capsule contains egg powder 190mg, interleukin-2 1500u, interferon 50u, thymosin for injection 25ug, transfer factor 0.00002u, hydrocortisone 150ug.
Embodiment 3
[0031] Take interleukin-2500000u, interferon 15000u, thymosin 2500ug, transfer factor 1u, hydrocortisone 100000ug and add 800mL eggs, stir evenly, dry and crush into egg powder, fill into No. 2 capsules to make 1000 capsules, Each capsule contains 190mg of egg powder, including interleukin-2500u, interferon 15u, thymosin for injection 2.5ug, transfer factor 0.001u, and hydrocortisone 100ug.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
Immunomodulatory pharmaceutical composition, each pharmaceutical dosage unit contains interleukin-25u~1500u, interferon 15u~1000u, thymosin 0.5ug~25ug, transfer factor 0.00002u~0.0015u, hydrocortisone 30ug~150ug, and is made of poultry eggs As an attachment agent, the above drug is added into poultry eggs, stirred evenly, dried and crushed into powder, and packed into capsules. The pharmaceutical composition can induce and stimulate the immune response to achieve the purposes of curing, preventing and maintaining health. Due to the small dose of active ingredients, there is no adverse toxic or side effect. After treating abdominal smooth muscle spasm, allergic purpura, diabetes, and vertigo, the curative effect is satisfactory.
Description
technical field [0001] The invention relates to a pharmaceutical composition, especially a pharmaceutical composition for immune regulation. The pharmaceutical composition of the invention can induce and stimulate human immune response to prevent and treat diseases. Background technique [0002] Cytokines are a general term for biologically active protein substances produced by cells. Cytokines are given to the body as drugs through various channels, and the biological effects of cytokines can be fully exerted, which can be used to resist and treat diseases. [0003] Reasonable doses and reasonable compatibility of trace cytokines, etc., can induce the immune response of Peyer's patches associated lymphoid tissue in the intestinal system, and the following effects can be obtained: [0004] 1. Anti-inflammatory effect [0005] It can inhibit inflammation caused by bacterial infection, immune, chemical, radiation and physical factors. Similar to glucocorticoids, it can pre...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more